Paradigm Biocapital Advisors LP - 20 Mar 2025 SCHEDULE 13G Report for LENZ Therapeutics, Inc. Common Stock, $0.00001 par value per share (LENZ)

Filing Manager: Paradigm Biocapital Advisors LP
Reporting Manager: Paradigm BioCapital Advisors LP
Security: LENZ Therapeutics, Inc. Common Stock, $0.00001 par value per share
Symbol: LENZ
Shares outstanding: 27.3M shares
Disclosed Ownership: 1.42M shares
Ownership: 5.2%
Form type: SCHEDULE 13G
Filing time: 27 Mar 2025, 16:21:15 UTC
Date of event: 20 Mar 2025
Next filing: 14 Nov 2025
SEC: View on sec.gov

Reporting Managers (4)

Name	Ownership	Shares Owned	sole voting power	Signature	Title
Paradigm BioCapital Advisors LP	5.2%	1.42M	1.42M	/s/ David K. Kim	David K. Kim / Authorized Signatory
Paradigm BioCapital Advisors GP LLC	5.2%	1.42M	1.42M	/s/ David K. Kim	David K. Kim / Authorized Signatory
Senai Asefaw, M.D.	5.2%	1.42M	1.42M	/s/ Senai Asefaw, M.D.	N/A
Paradigm BioCapital International Fund Ltd.	4.6%	1.25M	1.25M	/s/ David K. Kim	David K. Kim / Authorized Signatory